Deborah H Telman Gilead Sciences, Inc. (GILD) insider trading activity

Deborah H Telman is EVP, Corporate Affairs & GC of GILEAD SCIENCES, INC.. Currently has a direct ownership of 20,979 shares of GILD, which is worth approximately $1.86 Million. The most recent transaction as insider was on Oct 25, 2024, when has been sold 242 shares (Common Stock) at a price of $89.0 per share, resulting in proceeds of $21,538. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K

80.37% 3M change

210.25% 12M change

Total Value Held $1.86 Million

Deborah H Telman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 25 2024	SELL Payment of exercise price or tax liability	$21,538 $89.0 p/Share	242 Reduced 1.14%	20,979 Common Stock
Oct 25 2024	BUY Exercise of conversion of derivative security	-	514 Added 2.36%	21,221 Common Stock
Sep 10 2024	SELL Payment of exercise price or tax liability	$25,002 $81.44 p/Share	307 Reduced 1.46%	20,707 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	-	639 Added 2.95%	21,014 Common Stock
Jul 25 2024	SELL Payment of exercise price or tax liability	$223,179 $76.51 p/Share	2,917 Reduced 20.05%	11,631 Common Stock
Jul 25 2024	BUY Exercise of conversion of derivative security	-	8,744 Added 30.03%	20,375 Common Stock
Jun 10 2024	SELL Payment of exercise price or tax liability	$13,311 $65.25 p/Share	204 Reduced 1.38%	14,548 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	638 Added 4.15%	14,752 Common Stock
Apr 25 2024	SELL Payment of exercise price or tax liability	$10,312 $65.27 p/Share	158 Reduced 1.11%	14,114 Common Stock
Apr 25 2024	BUY Exercise of conversion of derivative security	-	515 Added 3.48%	14,272 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$63,551 $75.12 p/Share	846 Reduced 5.79%	13,757 Common Stock
Mar 10 2024	BUY Exercise of conversion of derivative security	-	2,555 Added 14.89%	14,603 Common Stock
Jan 31 2024	BUY Grant, award, or other acquisition	-	4,646 Added 28.37%	11,728 Common Stock
Jan 25 2024	SELL Payment of exercise price or tax liability	$15,564 $80.23 p/Share	194 Reduced 2.67%	7,082 Common Stock
Jan 25 2024	BUY Exercise of conversion of derivative security	-	514 Added 6.6%	7,276 Common Stock
Oct 25 2023	SELL Payment of exercise price or tax liability	$19,048 $78.39 p/Share	243 Reduced 3.47%	6,762 Common Stock
Oct 25 2023	BUY Exercise of conversion of derivative security	-	514 Added 6.84%	7,005 Common Stock
Jul 25 2023	SELL Payment of exercise price or tax liability	$322,358 $77.23 p/Share	4,174 Reduced 48.5%	4,433 Common Stock
Jul 25 2023	BUY Exercise of conversion of derivative security	-	10,289 Added 61.32%	6,491 Common Stock
Feb 15 2023	BUY Grant, award, or other acquisition	$21,198 $56.38 p/Share	376 Added 50.0%	376 Common Stock

Also insider at

OGN

Organon & Co. Healthcare

EVP GC & Corporate Secretary

ATRC

AtriCure, Inc. Healthcare

Director

DHT

Deborah H Telman

EVP, Corporate Affairs & GC

Jersey City, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Value

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

Operation

Value

Type

News

Receive news related to GILEAD SCIENCES, INC.

Track Activities on GILD

Account